Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well we know surgibot sucks bc they bought alfx
Also, the explanation that TRXC will handle ALF sales differently will not fly b/c if ALFx was superior technology, why haven't they sold it in 4 years? And why did TRXC get the technology on the cheap?
LTG are you saying that TRXC will wait 4 years to sell and commecialize ALF and SURGIBOT once they get FDA approval? If that is the case, I'd unload this stock ASAP. 4 years until they sell after FDA approval, wow!
LTG, Please explain why your company is going to wait 4 years upon approval to sell product?
LTG is your method of studying OSMOSIS? I took 30 seconds and found this information that confirms ALFx has had CE mark since Dec. 2011 BUT NO SALES. Should I lay down and put my laptop on my head to "STUDY UP" as you say. Do you want me to keep busting you up or will you go away? Come back when TRXC is at $14/share
http://surgrob.blogspot.com/2012/01/alf-x-telelap-getting-commercial.html
if it was superior technology it would have sold. So LTG, why hasn't any ALF-X been sold since CE mark approval in 2011? If it takes SPORT 5 years since CE mark to be given away for pennies on the dollar to another startup company I will be very, very ticked off not to mention I will be broke.
LTG, could you clarify, it appears that ALF gained CE mark and approval YET you say they didn't. Which is right?
http://surgrob.blogspot.com/2012/01/alf-x-telelap-getting-commercial.html
You are right LTG, ALF had commerical approval (CE mark) since DECEMBER 2011!!!! They are going on 5 years since CE Mark!!!! I was wrong it wasn't 2 years it was 5 years.
http://surgrob.blogspot.com/2012/01/alf-x-telelap-getting-commercial.html
Alfx has been approved for commercial sale for at least 3 years but hasn't sold. Usually superior technology would be purchased by customer. Alfx gives us a clear understanding of what the market things of that technology based on the fact that no one bought it. If no one buys Sport for the hospital or center for three years then Sport will not have good technology.
Product designed and developed by Ximedica - they are experts in medical device/product design. Versus a company that is trying to develop a product inhouse. Their understanding of building product based on the end user and human factors along with the regulatory understanding is a huge plus.
Obviously Peter lynch know squat about robotic surgery or the market, he's just putting something out there that his analyst said
TRXC went from $14/share down to $3/share in 1 year
the article mentions Titan getting FDA clearance by end of 2016
I firmly believe that when the Longtai deal gets finalized that a PO will follow closely behind it, hence my belief that one SPORT will be sold before one Surgibot. My belief that one SPORT will be sold before one ALF-X is that ALF-X has been available for sale for 2-3 years without one sale. Now some people don't consider sales outside the US (FDA approved) as sales (LTG) but every other human being knows that if you sell a product in Asia (for example), that revenue will count as a sale.
CE Approval - SALES. I can understand why you are confused, ALF-X has had CE mark for years but ZERO sales but that is very unusual. That only happens if a product sucks. In SPORTS case, once they get CE mark that will lead to sales.
could they be doing the offering and diluting b/c there is a possibility that they won't get FDA approval. Didn't they just get $50M about 3 months or so ago.
After hours trading on this has it going way down, might open tomorrow under $3/share.
TRXC down almost $1 after hours, looks like they are doing a $44 million offering - more dilution for TRXC
To add to that, I wouldn't take your opinion on anything about SPORT and Titan.
the big difference is that TRXC is trying to make a robot and they aren't a medical device design company. Sport has Ximedica which specializes in medical device, i believe at last count their were 51 specialized engineers working on completing SPORT. I'm willing to bet my investment that Ximedica has design freeze on SPORT - jmo.
That would be 24/7
that was sarcasm - i'm in agreement - institutional investor presentation, Sages, AORN - that is good exposure. Some people don't understand medical industry and think that you can just whip out the product like you are sampling turkey sausage at Costco. Sages and AORN alone takes a ton of effort/time/resources from even the seasoned medical device companies, its good to see Titan doing it.
There sure is an excuse for the PPS where it is right now and that is Market Manipulators. Real Simple - The surgical robotic market is exploding right now, there is ONLY ONE company that sells a product right now but 8-12 that are potential competitors, the ones closest to market that are public are being manipulated. It happens with TITXF, it happens with TRXC and it will happen to the next one that goes public.
The only way I will get paid is if Titan Mgmt can deliver a finished product to the market - that is the ONLY way. Things like a PR or a facebook post or a tweet don't mean anything until the product is done. In my 2 years of investing in Titan - mgmt has made SIGNIFICANT progress on getting SPORT Platform to the market and IMO have completed and frozen design.
I think he means that they should be showing SPORT 25/8
Isn't the fact that they will have the 5 units built for clinical trials evidence of Design Freeze? I'm reading the info as they have design freeze of the SPORT Surgical Robotic System. That and the fact that Ximedica is now promoting it points to Design Freeze.
Theory: Getting closer to completing the Longtai deal and part of that agreement was a PO for 10 Robots (pick any # of robots - used 10 for example), Titan needs the money to help produce the robots to fill the PO once the agreement is complete - need to pay Ximedica, Cadence and WW Supplier to make the robot and have their new Dir of Quality overseeing the process.
I thought you promised not to come back until TRXC was back at $14/share, that's what it was about a year ago.
Maybe they did notify them, maybe a company like trxc needs it to run to try and get their share price back up to $14/share. All of TRXC's PR releases never got the stock price going north, actually the stock price went down, especially since they bought ALF
Please keep that promise to not come back until Surgibot is sold and I will stop pointing out the deficiencies in your logic and the surgibot product.
SO TRXC has one guy doing FDA and SPORT has an entire company that specializes in FDA approval process, yet you say TRXC is better off. Makes no sense, but it doesn't make sense that someone would go by LTG and Bud to move a stock that was once at $14/share. Also, TRXC has no domestic sales force, no service technicians, no clinical specialist AND NO FDA approval.
Hey Bud, it's not jumping b/c of TRXC - It's jumping b/c investors are starting to see that its a next generation robotic surgery platform. TRXC is jumping b/c of rumors. Big difference.
But they outsourced the development of SPORT to an a company that specializes in FDA process and procedure. TRXC has no one on staff that can do that.
Is TRXC going to reverse split again?
Before Surgibot, make sure you are accurate with your info (hard for you). Also, TRXC is a long way from $14/share. They don't have FDA Approval yet and it could be delayed - Q2 is right around the corner and TRXC is hiring no sales people and are STILL looking for a regulatory person - looks like they could be having problems navigating the FDA process.
Stock could drop all the way back under $2 as soon as the rumor of acquisition gets quelled. This TRXC action is all based on a rumor not the promise of FDA approval of Surgibot.
LTG or Bud, whichever you go by this week, surgibot still isn't FDA approved and could possibly be delayed. I stand by my opinion - Titan gets a PO for Sport before Surgibot is sold.
who's going to buy it?
be more specific next time b/c you were telling all those that own warrants to exercise them.
you won't but you ask others to exercise their warrants? that doesn't make sense to me
Based on his past post, he had to have owned some dec warrants. Hence the meltdown when TITXF didn't hit the strike price in December
Are you going to exercise your E's next week?
HC, why didn't you exercise your Dec. Warrants?
Why didn't warrant holders exercise when they had the chance? An example, the Dec warrants holders had a chance to exercise when the price had gone up before but they didn't and got burned. But now other warrant holders are being asked to exercise now, I don't understand that.